ARDC Research Link Australia Research Link Australia   BETA Research
Link
Australia
  • ARDC Newsletter Subscribe
  • Contact Us
  • Home
  • About
  • Feedback
  • Explore Collaborations
  • Researcher
  • Funded Activity
  • Organisation
  • Researcher
  • Funded Activity
  • Organisation
  • Researcher
  • Funded Activity
  • Organisation

Need help searching? View our Search Guide.

Advanced Search

Current Selection
Research Topic : APOPTOSIS
Scheme : Project Grants
Clear All
Filter by Field of Research
Cell Development, Proliferation and Death (27)
Cellular Immunology (5)
Structural Biology (incl. Macromolecular Modelling) (5)
Cancer Cell Biology (4)
Biochemistry and Cell Biology not elsewhere classified (3)
Medical Virology (3)
Signal Transduction (3)
Autoimmunity (2)
Haematology (2)
Neurogenetics (2)
Anaesthesiology (1)
Biologically Active Molecules (1)
Cancer Therapy (excl. Chemotherapy and Radiation Therapy) (1)
Cellular Nervous System (1)
Chemotherapy (1)
Gene Expression (incl. Microarray and other genome-wide approaches) (1)
Haematological Tumours (1)
Humoural Immunology and Immunochemistry (1)
Medical Physiology not elsewhere classified (1)
Molecular Medicine (1)
Molecular Targets (1)
Neurology and Neuromuscular Diseases (1)
Obstetrics and Gynaecology (1)
Reproduction (1)
Solid Tumours (1)
Surgery (1)
Filter by Socio-Economic Objective
Search did not return any results.
Filter by Funding Provider
National Health and Medical Research Council (72)
Filter by Status
Closed (72)
Filter by Scheme
Project Grants (72)
Filter by Country
Australia (12)
India (1)
Filter by Australian State/Territory
VIC (11)
WA (1)
  • Researchers (0)
  • Funded Activities (72)
  • Organisations (32)
  • Funded Activity

    TAF8 Is A Suppressor Of Cell Death

    Funder
    National Health and Medical Research Council
    Funding Amount
    $570,433.00
    Summary
    TAF8 is a small protein that is associated with the general transcriptional apparatus. TAF8 is not an essential part of the general transcriptional machinery, but rather a regulatory molecule that appears to dictate how the machinery is used to express different genes. The absence of TAF8 leads to expression of genes controlling cell death. Since the avoidence of cell death is essential to the development of cancer these results will lead to a better understanding of how cancer develops.
    More information
    Funded Activity

    Small Molecule Apoptosis Inhibitors To Define The Bak Activating Switch

    Funder
    National Health and Medical Research Council
    Funding Amount
    $713,687.00
    Summary
    Tissue loss due to excessive apoptosis is a contributing factor to organ transplant failure and other diseases characterised by too much cell death. Using an innovative cell-based screening approach, we have identified a first in class series of molecules that potently block cell death driven by the apoptosis effector Bak. By unravelling the molecular target of our unique inhibitors and characterising their mode of action, we hope to uncover a new facet of Bax and Bak biology.
    More information
    Funded Activity

    Molecular Regulation Of Apoptosis In Endothelial Cells

    Funder
    National Health and Medical Research Council
    Funding Amount
    $593,888.00
    Summary
    This project seeks to understand the mechanisms by which cells that make up our blood vessels are kept alive. Impaired blood vessel cell survival contributes to reduced blood vessel health, a major component of cardiovascular disease. Knowledge of how these cells are kept alive could prove useful in treating diseases affecting vessel cell survival, or potentially to combat those diseases that are caused by excessive blood vessel growth.
    More information
    Funded Activity

    The Role Of Bid In Apoptosis Within The Ovary

    Funder
    National Health and Medical Research Council
    Funding Amount
    $459,843.00
    Summary
    Women are born with a limited supply of eggs and are unable to make new eggs after birth. Because of this, the number and health of eggs established within the ovary early in life influence the length of time for which a female will be fertile, her age at menopause, and the health of her offspring. This project aims to shed some light on the mechanisms that control egg supply and reproductive longevity in women by investigating the role of the cell death protein Bid within the ovary.
    More information
    Funded Activity

    Role Of The Mitochondrial Membrane In Apoptosis

    Funder
    National Health and Medical Research Council
    Funding Amount
    $536,668.00
    Summary
    The Bcl-2 family of proteins is crucial for apoptosis (a form of programmed cell death) regulation. They target the mitochondrial outer membrane where they interact to determine cell fate. We will evaluate the membrane interactions of the Bcl-2 proteins in complementary biophysical and cellular experiments to redefine our understanding of the mechanism of apoptosis and provide new avenues for the development of compounds to selectively modulate diseases in which apoptosis is unregulated.
    More information
    Funded Activity

    The Influence Of NF-KB In The Development Of Autoimmunity And Cancer In Fas/FasL Mutant Mice

    Funder
    National Health and Medical Research Council
    Funding Amount
    $596,925.00
    Summary
    Apoptotic cell death is an essential process in the human body, it removes useless and dangerous cells, preventing autoimmune disease and cancer. Apoptosis is activated when the surface receptor Fas is stimulated by its ligand, FasL, but defective signalling causes disease associated with deregulated NF-?B activation. We will investigate how faulty FasL-induced apoptosis cooperates with deregulated NF-kB activation or defective Aire (immunological tolerance orchestrator) results in autoimmunity.
    More information
    Funded Activity

    Investigating The Role Of Mutant P53 And MCL-1 In The Sustained Growth Of MYC Lymphomas And Strategies For Targeted Therapy

    Funder
    National Health and Medical Research Council
    Funding Amount
    $616,940.00
    Summary
    A large number of human cancers have abnormal expression of a protein called MYC, leading to rapid growth. We found that when another protein called MCL-1 was inactivated, the lymphomas regressed. Importantly, mutations in the tumour suppressor gene called p53 are frequently found in cancer cells and we noticed that this could reduce the dependency on MCL-1. We aim to investigate this further in this grant proposal, in part using a novel drug that targets MCL-1.
    More information
    Funded Activity

    Developing A New Treatment Method To Prevent Lymphopenia Associated With Sepsis

    Funder
    National Health and Medical Research Council
    Funding Amount
    $435,939.00
    Summary
    Sepsis or blood poisoning kills more people than breast cancer, prostate cancer and HIV/AIDS combined. It has a huge economic burden, yet there is no proper diagnostics markers or treatment. One of the main reasons for sepsis-mediated mortality is lack of functioning immune system patients. We have been able to elucidate the molecular mechanism of sepsis-mediated immune cell death and through this project, we aim to develop diagnostics and therapy for treating sepsis-mediated immune suppression.
    More information
    Funded Activity

    Targeting Bcl-2 Pathways In Parasites

    Funder
    National Health and Medical Research Council
    Funding Amount
    $486,610.00
    Summary
    Schistosomiasis is one of the world's most serious and prevalent diseases affecting nearly 200 million people world-wide. It is currently treated with a single drug, though there is growing concern about the development of resistance to it. In this proposal we will explore whether a new cellular pathway involving the cell death machinery we have identified in the disease-causing parasites could provide a possible target for the development of new treatments against schistosomiasis.
    More information
    Funded Activity

    Structural Investigations Of The Bax And Bak Cell Death Apparatus

    Funder
    National Health and Medical Research Council
    Funding Amount
    $275,509.00
    Summary
    Programmed cell death is a process by which the body keeps rogue cells in check. Cancer cells adapt to avoid this process and thus evade this important defence mechanism. This project seeks to understand the machinery that controls programmed cell death at the molecular level. It will provide the atomic details of how this machinery is regulated and how it functions to induce cell death. These insights will provide new avenues for targeting this machinery for a new generation of cancer therapeut .... Programmed cell death is a process by which the body keeps rogue cells in check. Cancer cells adapt to avoid this process and thus evade this important defence mechanism. This project seeks to understand the machinery that controls programmed cell death at the molecular level. It will provide the atomic details of how this machinery is regulated and how it functions to induce cell death. These insights will provide new avenues for targeting this machinery for a new generation of cancer therapeutics.
    Read more Read less
    More information

    Showing 1-10 of 72 Funded Activites

    • 1
    • 2
    • 3
    • 4
    • 5
    Advanced Search

    Advanced search on the Researcher index.

    Advanced search on the Funded Activity index.

    Advanced search on the Organisation index.

    National Collaborative Research Infrastructure Strategy

    The Australian Research Data Commons is enabled by NCRIS.

    ARDC CONNECT NEWSLETTER

    Subscribe to the ARDC Connect Newsletter to keep up-to-date with the latest digital research news, events, resources, career opportunities and more.

    Subscribe

    Quick Links

    • Home
    • About Research Link Australia
    • Product Roadmap
    • Documentation
    • Disclaimer
    • Contact ARDC

    We acknowledge and celebrate the First Australians on whose traditional lands we live and work, and we pay our respects to Elders past, present and emerging.

    Copyright © ARDC. ACN 633 798 857 Terms and Conditions Privacy Policy Accessibility Statement
    Top
    Quick Feedback